Unknown NA INTERVENTIONAL NCT00182377

Pentastarch Use in Cardiac Surgery

A Randomized, Prospective, Blinded Clinical Trial to Evaluate the Efficacy and Safety of Pentastarch Use in Patients Undergoing Coronary Artery Bypass Surgery or Valve Replacement Surgery Using Cardiopulmonary Bypass Circuits

Sponsor: Hamilton Health Sciences Corporation

Conditions Cardiac Surgery Cardiopulmonary Bypass

Interventions Pentastarch (displace either 500 ml or 1000 ml of pump prime with pentastarch)

Updated 5 times since 2017 Last updated: Sep 19, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cardiac Surgery and Cardiopulmonary Bypass, this trial is ongoing. The trial is conducted by Hamilton Health Sciences Corporation and has accumulated 5 data snapshots since 2026. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hamilton Health Sciences Corporation

Data source: McMaster University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada